Literature DB >> 2380366

Semiquantitative technique for estimating Pneumocystis carinii burden in the lung.

R P Baughman1, S Strohofer, G Colangelo, P T Frame.   

Abstract

We developed a technique to estimate the amount of Pneumocystis carinii found in bronchoalveolar lavage fluid. P. carinii associated with 500 nucleated cells in the bronchoalveolar lavage fluid had little between-observer and within-observer variation. Varying the technique of the lavage did not change the amount of P. carinii recovered. This technique was used in patients treated for P. carinii pneumonia. Those patients who did not respond to treatment had more P. carinii in their bronchoalveolar lavage fluid than those who responded.

Entities:  

Mesh:

Year:  1990        PMID: 2380366      PMCID: PMC267944          DOI: 10.1128/jcm.28.6.1425-1427.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Variation of differential cell counts of bronchoalveolar lavage fluid.

Authors:  R Baughman; S Strohofer; C K Kim
Journal:  Arch Pathol Lab Med       Date:  1986-04       Impact factor: 5.534

2.  Use of a rapid differential stain for identifying Pneumocystis carinii in bronchoalveolar lavage fluid. Diagnostic efficacy in patients with AIDS.

Authors:  D J Tollerud; T A Wesseler; C K Kim; R P Baughman
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

3.  NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop.

Authors:  J F Murray; S M Garay; P C Hopewell; J Mills; G L Snider; D E Stover
Journal:  Am Rev Respir Dis       Date:  1987-02

4.  Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome.

Authors:  C Broaddus; M D Dake; M S Stulbarg; W Blumenfeld; W K Hadley; J A Golden; P C Hopewell
Journal:  Ann Intern Med       Date:  1985-06       Impact factor: 25.391

5.  Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome.

Authors:  J A Golden; H Hollander; M S Stulbarg; G Gamsu
Journal:  Chest       Date:  1986-07       Impact factor: 9.410

6.  Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host.

Authors:  D E Stover; M B Zaman; S I Hajdu; M Lange; J Gold; D Armstrong
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

7.  Value of repeat fiberoptic bronchoscopies and significance of nondiagnostic bronchoscopic results in patients with the acquired immunodeficiency syndrome.

Authors:  J L Barrio; C Harcup; H J Baier; A E Pitchenik
Journal:  Am Rev Respir Dis       Date:  1987-02

8.  Assessment of therapy for pneumocystis carinii pneumonia. PCP Therapy Project Group.

Authors:  H W Haverkos
Journal:  Am J Med       Date:  1984-03       Impact factor: 4.965

9.  Persistence of Pneumocystis carinii in lung tissue of acquired immunodeficiency syndrome patients treated for pneumocystis pneumonia.

Authors:  J H Shelhamer; F P Ognibene; A M Macher; C Tuazon; R Steiss; D Longo; J A Kovacs; M M Parker; C Natanson; H C Lane
Journal:  Am Rev Respir Dis       Date:  1984-12

10.  Effect of changing instilled volume for bronchoalveolar lavage in patients with interstitial lung disease.

Authors:  M N Dohn; R P Baughman
Journal:  Am Rev Respir Dis       Date:  1985-08
View more
  3 in total

1.  Sterols of Pneumocystis carinii hominis organisms isolated from human lungs.

Authors:  E S Kaneshiro; Z Amit; J Chandra; R P Baughman; C Contini; B Lundgren
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

2.  Use of bronchoscopy in the diagnosis of infection in the immunocompromised host.

Authors:  R P Baughman
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

3.  The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia.

Authors:  Chung-Wei Chou; Fang-Chi Lin; Han-Chen Tsai; Shi-Chuan Chang
Journal:  BMC Pulm Med       Date:  2014-11-19       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.